Literature DB >> 17420701

Full-thickness macular hole formation in idiopathic parafoveal telangiectasis.

Hideki Koizumi1, Jason S Slakter, Richard F Spaide.   

Abstract

PURPOSE: To describe the macular holes in patients with idiopathic parafoveal telangiectasis (IPT) and to propose a pathophysiologic explanation for their formation.
METHODS: Four eyes of two patients with IPT were evaluated with biomicroscopy and optical coherence tomography (OCT).
RESULTS: One patient had a nearly full-thickness hole with preservation of only the internal limiting membrane (ILM), but had a 20/60 visual acuity. The other patient had a large full-thickness macular hole, but retained 20/40 visual acuity. Each patient had a fellow eye showing prominent central inner foveal cavitation under a very thin ILM, which was devoid of associated tissue.
CONCLUSIONS: This report describes the findings of two patients with IPT who developed pronounced central foveal structural abnormalities. The induced anatomic changes noted in our patients suggest that there is a loss of the structural aspects afforded by Muller cells, particularly the Muller cell cone, in the central macula in patients with IPT. The preservation of good visual acuity in our patients implies that the holes were the result of lateral separation of the photoreceptors within the fovea and that there could not have been profound atrophy of the photoreceptors.

Entities:  

Mesh:

Year:  2007        PMID: 17420701     DOI: 10.1097/01.iae.0000246678.93495.2f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  16 in total

1.  Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.

Authors:  Jing Hua; Karen I Guerin; Jing Chen; Shaday Michán; Andreas Stahl; Nathan M Krah; Molly R Seaward; Roberta J Dennison; Aimee M Juan; Colman J Hatton; Przemyslaw Sapieha; David A Sinclair; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

2.  Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis.

Authors:  Hideki Koizumi; Michael J Cooney; Anita Leys; Richard F Spaide
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

3.  "Doctor, why is my macular hole still open?".

Authors:  Mei Hong Tan; Fred Kuanfu Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-18       Impact factor: 3.117

4.  Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia.

Authors:  Dhananjay Shukla; Ramesh Venkatesh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-22       Impact factor: 3.117

5.  Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia.

Authors:  D Shukla
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

6.  Müller cell alignment in bird fovea: possible role in vision.

Authors:  Serguei Skatchkov; Mikhail Inyushin; Lidia Zueva; Vladimir Makarov; Astrid Zayas-Santiago; Tatiana Golubeva; Elena Korneeva; Alexey Savvinov; Misty Eaton
Journal:  J Neurosci Neuroeng       Date:  2014-12-01

7.  Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.

Authors:  Berna Dogan; Muhammet Kazim Erol; Melih Akidan; Elcin Suren; Yusuf Akar
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

8.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 9.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

10.  Familial asymptomatic macular telangiectasia type 2.

Authors:  Mark C Gillies; Meidong Zhu; Emily Chew; Daniel Barthelmes; Edward Hughes; Haipha Ali; Frank G Holz; Hendrik P N Scholl; Peter Charbel Issa
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.